← Back to Analyst Consensus 
IDXX Buy
IDEXX LABORATORIES INC /DE
Current Price —
Implied Upside —
Analysts 21
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 1 reiterations from 2 firms
Next Earnings
Nov 2, 2026 (6 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 16, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Oct 12, 2026 | Keybanc | initiate | — → Sector Weight | — | 52% |
| Aug 11, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Aug 5, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 5, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Jul 27, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Apr 28, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Apr 15, 2026 | Citigroup | initiate | — → Neutral | — | 54% |
| Mar 31, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Feb 9, 2026 | Piper Sandler | maintain | Neutral → Neutral | $750 | 54% |
| Feb 5, 2026 | Barclays | maintain | Overweight → Overweight | $800 | 53% |
| Feb 3, 2026 | UBS | maintain | Neutral → Neutral | $730 | 54% |
| Feb 3, 2026 | BTIG | maintain | Buy → Buy | $800 | 52% |
| Dec 9, 2025 | Barclays | initiate | — → Overweight | $850 | 53% |
| Nov 4, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $805 | 54% |
| Nov 4, 2025 | UBS | maintain | Neutral → Neutral | $750 | 54% |
| Nov 4, 2025 | JP Morgan | maintain | Overweight → Overweight | $775 | 55% |
| Nov 4, 2025 | BTIG | maintain | Buy → Buy | $830 | 52% |
| Oct 31, 2025 | Stifel | upgrade | Hold → Buy | $700 | 53% |
| Oct 1, 2025 | UBS | initiate | — → Neutral | $720 | 54% |
| Aug 15, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $765 | 54% |
| Aug 11, 2025 | Piper Sandler | maintain | Neutral → Neutral | $700 | 54% |
| Aug 4, 2025 | JP Morgan | maintain | Overweight → Overweight | $675 | 55% |
| Aug 4, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $722 | 54% |
| Jul 29, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $628 | 54% |
| Jul 17, 2025 | Leerink Partners | maintain | Outperform → Outperform | $600 | 51% |
| Jul 2, 2025 | Stifel | maintain | Hold → Hold | $540 | 53% |
| Jun 11, 2025 | Leerink Partners | maintain | Outperform → Outperform | $580 | 51% |
| May 19, 2025 | Stifel | maintain | Hold → Hold | $510 | 53% |
| May 5, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $558 | 54% |
| May 1, 2025 | Stifel | maintain | Hold → Hold | $460 | 53% |
| Apr 21, 2025 | B of A Securities | maintain | Neutral → Neutral | $475 | 53% |
| Apr 15, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $548 | 54% |
| Apr 14, 2025 | Stifel | maintain | Hold → Hold | $420 | 53% |
| Feb 28, 2025 | Stifel | maintain | Hold → Hold | $450 | 53% |
| Feb 10, 2025 | Piper Sandler | maintain | Neutral → Neutral | $510 | 54% |
| Feb 4, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $559 | 54% |
| Feb 4, 2025 | Barclays | maintain | Overweight → Overweight | $520 | 53% |
| Feb 4, 2025 | B of A Securities | maintain | Neutral → Neutral | $535 | 53% |
| Feb 3, 2025 | Stifel | maintain | Hold → Hold | $460 | 53% |
| Jan 29, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $550 | 54% |
| Dec 2, 2024 | Leerink Partners | initiate | — → Outperform | $500 | 51% |
| Nov 4, 2024 | Piper Sandler | reiterate | Neutral → Neutral | $435 | 54% |
| Nov 4, 2024 | Barclays | maintain | Overweight → Overweight | $481 | 53% |
| Oct 11, 2024 | JP Morgan | maintain | Overweight → Overweight | $575 | 55% |
| Oct 10, 2024 | Stifel | maintain | Hold → Hold | $500 | 53% |
| Aug 14, 2024 | Piper Sandler | maintain | Neutral → Neutral | $520 | 54% |
| Jul 25, 2024 | BTIG | initiate | — → Buy | $580 | 52% |
| Jun 24, 2024 | Stifel | maintain | Hold → Hold | $510 | 53% |
| May 14, 2024 | Morgan Stanley | maintain | Overweight → Overweight | $596 | 54% |
Price Target Trend
Jul 9, 2026 Oct 27, 2026
EPS Estimates
0q —
+1q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days